Malaria kills 610,000 people each year, with 95% of deaths occurring in Sub-Saharan Africa. Pharmakina is the continent's only producer of quinine-based malaria treatments, delivering over 7 million treatment courses annually from their facility in the DRC.

‍

The company operates a fully vertically integrated model: growing cinchona trees, extracting the active pharmaceutical ingredient, and manufacturing finished medicines on-site. This approach creates jobs at every stage of production while keeping critical medicine affordable and accessible across the region.

‍

Talanton's investment will help Pharmakina double their API extraction capacity and expand their network of smallholder farmers from 2,500 to over 5,500.

‍

Impact: 870 full-time employees | 2,500+ smallholder farmers | 7M+ malaria treatments annually

‍